An innovative method to generate a Good Manufacturing Practice–ready regulatory T-cell product from non-mobilized leukapheresis donors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An innovative method to generate a Good Manufacturing Practice–ready regulatory T-cell product from non-mobilized leukapheresis donors

Published:2015-09 Issue:9 Volume:17 Page:1268-1279
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Zhang Wei,Smythe Jon,Frith Emma,Belfield Helen,Clarke Sophie,Watt Suzanne M.,Danby Robert,Benjamin Sylvia,Peniket Andy,Roberts David J.

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference27 articles.

1. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance;Sakaguchi;Immunol Rev,2001

2. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation;Edinger;Nat Med,2003

3. CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease;Cohen;J Exp Med,2002

4. Advances in graft-versus-host disease biology and therapy;Blazar;Nat Rev Immunol,2012

5. Preparation of functionally preserved CD4+ CD25high regulatory T cells from leukapheresis products from ulcerative colitis patients, applicable to regulatory T-cell transfer therapy;Sumida;Cytotherapy,2008

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Migratory Properties and Numbers of T Regulatory Cell Subsets in Circulation Are Differentially Influenced by Season and Are Associated With Vitamin D Status;Frontiers in Immunology;2020-05-19

2. An Innovative Standard Operation Procedure for Isolating GMP-Grade CD4+CD25+ T Cells from Non-Mobilized Leukapheresis;Methods in Molecular Biology;2019

3. Clinical Grade Regulatory CD4+ T Cells (Tregs): Moving Toward Cellular-Based Immunomodulatory Therapies;Frontiers in Immunology;2018-02-13

4. Measuring the resting naive sub-population of T-regulatory cells improves prediction of suppressive function of clinical grade T-regulatory products;Cytotherapy;2017-03

5. A robust, good manufacturing practice–compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy;Cytotherapy;2016-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3